Patients switching from Pfizer’s branded cholesterol pill Lipitor to Merck & Co’s Zocor — now available as a cheap generic — are more likely to have a heart attack or die, according to a Pfizer-backed study.
Go to the Story » Discuss Tell a friendBury
BroadcastHealth enables you to find the best stories about health on the web. Users in the community submit and vote on stories to bring you the best content available. Create and broadcast the stories that are important to you!
Learn More!
Comments